Convatec Group PLC

Board/Management Information • May 3, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0252N

ConvaTec Group PLC

03 May 2018

ConvaTec Director Declaration

Reading, United Kingdom (3 May 2018)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Ros Rivaz, an Independent Non-Executive Director of the Company, has been appointed as an Independent Non-Executive Director of CEVA Logistics AG, with effect from today.

After an initial public offering, it is anticipated that CEVA's registered shares will be listed on the SIX Swiss Exchange with effect from 4 May 2018.

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226

Alastair Elwen, Finsbury                                                             +44 (0)207 251 3801

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                             +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, ConvaTec                         +44 (0)7470 909 582

investorrelations@convatec.com

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNUGUAWAUPRUBW